The Use of Greater Saphenous Vein In Situ Graft in Arterial Occlusive Disease of Lower Extremity.
- Author:
Yong Chul SHIN
1
;
Mi Jung KIM
;
Chang Min SONG
;
Jae Bum AHN
;
In Sub KIM
;
Woo Sik KIM
;
Byung Yul KIM
Author Information
1. Department of Thoracic & Cardiovascular Surgery, National Medical Center, Korea. chy5139@hanmail.net
- Publication Type:Original Article
- Keywords:
Saphenous vein;
Arterial occlusive disease;
Graft
- MeSH:
Aneurysm;
Arterial Occlusive Diseases*;
Follow-Up Studies;
Humans;
Lower Extremity*;
Phenobarbital;
Popliteal Artery;
Postoperative Complications;
Retrospective Studies;
Saphenous Vein*;
Seroma;
Transplants*;
Wounds and Injuries
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2006;39(6):456-461
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Distal anastomosis using artificial vascular graft is difficult when luminal size mismatch occurred owing to severe occlusion of popliteal artery and its branches. So we reconstructed blood flow to ischemic lower limb by using autologous greater saphenous vein in situ graft (GSVISG) as vascular graft material. MATERIAL AND METHOD: From July 2000 to July 2005, 26 patients treated using GSVISG. We analyzed clinical results retrospectively by chart review. RESULT: There was no in hospital or early postoperative death and 6 late deaths occurred during follow up period. Postoperative complications were 5 cases of early graft obstruction, 2 cases of wound dehiscence, 1 case of graft aneurysmal change, 1 case of seroma formation at inguinal wound and 1 case of graft injury during valvulotomy. Overall patency rate during follow up period was 69.3%. CONCLUSION: Greater saphenous vein in situ graft is acceptable vascular graft for arterial occlusive disease of lower extremity.
